The U.S. FDA approves the use of plasma from survivors of the novel coronavirus as a treatment method
The U.S. Food and Drug Administration (FDA) announced on Sunday (23rd) that it has approved the use of plasma from patients who have recovered from the novel coronavirus as a treatment for the disease, and issued an emergency use permit. The FDA stated in a statement that plasma therapy may be effective in treating the new coronavirus, and its known and potential benefits outweigh the risks, and pointed out that more than 70,000 patients with the new coronavirus have used plasma therapy. However, the effectiveness of this therapy is still questioned by some foreign experts, and even warned that plasma therapy may have side effects “serum sickness”, which may lead to organ failure in severe cases.
New Zealand will extend the local three-level lockdown measures by one more week
New Zealand Prime Minister Ardern announced on Monday (24th) that the local three-level lockdown measures will be extended for at least one week, including forcing people to wear masks on public transportation. Affected by the epidemic lockdown measures, New Zealand’s retail sales fell 14.2% year-on-year in the second quarter of this year, ending the quarterly upward trend and marking the largest decline in 25 years. The market estimates that under the blockade restrictions, it will cause about 440 million New Zealand dollars in economic losses every week, equivalent to 0.15% of the annual GDP. If the blockade measures are not lifted in the short term, it will have a major impact on the local economy.
Z. com Bullion is an affiliate of GMO Financial Holdings, Inc., a Japanese listed group. The risk of loss in leveraged foreign exchange trading & margin trading can be substantial. Visit the company website to read full risk warning. https://bullion.z.com/en/about/legal/risk/